In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis
NCT02852850 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2016-10-17
Summary
Molecular imaging with infliximab antibody with FITC has the potential to predict therapeutic responses to infliximab antibody and can be used for personalized medicine in ulcerative colitis.
Conditions
Sponsors & Collaborators
-
Shandong University
lead OTHER
Principal Investigators
-
Yanqing Li, MD,PHD · Qilu Hospital of Shandong University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2018-06-30
Countries
- China
Study Locations
More Related Trials
-
Texture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel Diseases
NCT06892990 ·Status: RECRUITING ·Phase: NA
-
RCT: HDWL vs Virtual Chromoendoscopy in the Detection of Intraepithelial Neoplasia in Longstanding Colitis
NCT02822352 ·Status: COMPLETED ·Phase: NA
-
Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease
NCT05151458 ·Status: UNKNOWN
-
Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence
NCT04131530 ·Status: UNKNOWN
-
Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease
NCT07258641 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis
NCT03863886 ·Status: UNKNOWN ·Phase: NA
-
Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis
NCT07111572 ·Status: NOT_YET_RECRUITING
-
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
NCT02438410 ·Status: COMPLETED
-
Transperineal Ultrasound for Assessing and Predicting Response in Hospitalized Patients with a Flare of Ulcerative Colitis
NCT06496516 ·Status: NOT_YET_RECRUITING
-
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
NCT00656890 ·Status: COMPLETED ·Phase: PHASE2
-
Effect and Mechanism of Dopamine on Ulcerative Colitis
NCT05214404 ·Status: COMPLETED
-
PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
NCT01759017 ·Status: TERMINATED
-
A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis
NCT00295282 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
NCT01551290 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease
NCT00269841 ·Status: COMPLETED ·Phase: PHASE3
-
An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese Patients
NCT06961435 ·Status: COMPLETED
-
Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease
NCT07181525 ·Status: RECRUITING
-
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)
NCT01289366 ·Status: COMPLETED
-
Development and Validation of a Deep Learning Algorithm to Evaluate Endoscopic Disease Activity of Ulcerative Colitis.
NCT03973437 ·Status: UNKNOWN ·Phase: NA
-
Multi-omics to Predict Responses to Biologics in IBD
NCT05542459 ·Status: UNKNOWN
-
The Associations of Microribonucleic Acid Gene Polymorphisms With the Risk of Ulcerative Colitis
NCT06873711 ·Status: COMPLETED
-
Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)
NCT00205062 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Inflammation Activity in Ulcerative Colitis by pCLE
NCT03788824 ·Status: UNKNOWN
-
Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis
NCT02922374 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Response Assessment in SB CD
NCT03646708 ·Status: ACTIVE_NOT_RECRUITING